Barbara Denys

Journal Article
A1
open access

Flow cytometry interference in patients treated with tafasitamab : unraveling the diagnostic maze

Lisa Proost, Stijn Lambrecht (UGent) , Mattias Hofmans (UGent) , Ciel De Vriendt (UGent) , Marijn Speeckaert (UGent) , Carolien Bonroy (UGent) , Barbara Denys (UGent) and Sander De Bruyne

(2024) HEMASPHERE. 8(1).

Add to list

The added value of automated HPC count : detecting clinically important interferences on the flow cytometric CD34+cell count

Alice Brochier (UGent) , Mattias Hofmans (UGent) , Stijn Lambrecht (UGent) , Pauline Breughe (UGent) , Barbara Denys (UGent) , Sander De Bruyne, Malicorne Buysse (UGent) , Anna Vantilborgh (UGent) and Carolien Bonroy (UGent)

(2024) CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 62(7). p.e160-e163

Add to list

Conference Paper
C3
open access

Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN

Philippe Decruyenaere (UGent) , Dominiek Mazure (UGent) , Ine Moors (UGent) , Jo Van Dorpe (UGent) , Malaïka Van der Linden (UGent) , Barbara Denys (UGent) , Mattias Hofmans (UGent) and Fritz Offner (UGent)

(2023) 38th General Annual Meeting of the Belgian Hematology Society 2023, Abstracts.

Add to list

Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature

Philippe Decruyenaere (UGent) , Dominiek Mazure (UGent) , Ine Moors (UGent) , Jo Van Dorpe (UGent) , Malaïka Van der Linden (UGent) , Barbara Denys (UGent) , Mattias Hofmans (UGent) and Fritz Offner (UGent)

(2023) ACTA CLINICA BELGICA. 78(1). p.58-66

Add to list

Journal Article
A1
open access

Technical aspects of flow cytometry-based measurable residual disease quantification in acute myeloid leukemia : experience of the European LeukemiaNet MRD Working Party

Jesse M. Tettero, Sylvie Freeman, Veit Buecklein, Adriano Venditti, Luca Maurillo, Wolfgang Kern, Roland B. Walter, Brent L. Wood, Christophe Roumier, Jan Philippé (UGent) , et al.

(2022) HEMASPHERE. 6(1).

Add to list

Journal Article
A1
open access

Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm

Sander De Bruyne, EVA STEEL (UGent) , Marjan Petrick (UGent) , Barbara Denys (UGent) , Karl Vandepoele (UGent) , Nadine Van Roy (UGent) , Simon Degandt, Timothy Ghys and Henk Louagie (UGent)

(2021) CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 59(10). p.E392-E394

Add to list

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Barbara Depreter, Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Eva Terras (UGent) , Barbara Denys (UGent) , Laurence Dedeken, Marie-Francoise Dresse, Jutte Van der Werff Ten Bosch, et al.

(2021) PEDIATRIC RESEARCH. 89(7). p.1695-1705

Add to list

Journal Article
A1
open access

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , Magnus Essand, Barbara De Moerloose (UGent) , Maria Themeli, Jacqueline Cloos, Diana Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2020) HAEMATOLOGICA. 105(5). p.1306-1316

Add to list

Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01

Barbara De Moerloose (UGent) , Ardine Reedijk, Geertruida H. de Bock, Tim Lammens (UGent) , Valerie de Haas, Barbara Denys (UGent) , Laurence Dedeken, Marry M. van den Heuvel-Eibrink, Maroeska te Loo, Anne Uyttebroeck, et al.

(2019) PEDIATRIC BLOOD & CANCER. 66(5).

Add to list

Conference Paper
C3
open access

TARP as immunotherapeutic target in AML expressed in the LSC compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , M Essand, Barbara De Moerloose (UGent) , M Themeli, J Cloos, D Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2019) HEMASPHERE. 3(suppl. 1). p.54-54

Academic Bibliography

Barbara Denys

Flow cytometry interference in patients treated with tafasitamab : unraveling the diagnostic maze

The added value of automated HPC count : detecting clinically important interferences on the flow cytometric CD34+cell count

Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN

Systemic mastocytosis with myeloid sarcoma and B-CLL : molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature

Technical aspects of flow cytometry-based measurable residual disease quantification in acute myeloid leukemia : experience of the European LeukemiaNet MRD Working Party

Development of chronic myeloid leukemia in a patient previously diagnosed with a JAK2-positive myeloproliferative neoplasm

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01

TARP as immunotherapeutic target in AML expressed in the LSC compartment

Contents

Support

Contact